J. Goldman & Co’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.59M | Sell |
|
|||||
|
2025
Q2 | $10.6M | Sell |
|
|||||
|
2025
Q1 | $10.8M | Buy |
|
|||||
|
2024
Q4 | $6.24M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $4.92M | Buy |
|
|||||
|
2024
Q1 | $2.74M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $8.99M | Sell |
|
|||||
|
2023
Q2 | $8.05M | Buy |
|
|||||
|
2023
Q1 | $883K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $4.82M | Buy |
|
|||||
|
2022
Q2 | $739K | Buy |
|
|||||
|
2022
Q1 | – | Hold |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $2.02M | Buy |
|